Belviq Withdrawn from the US Market Due to Potential Cancer Risk

On February 13, 2020 The U.S. Food and Drug Administration (FDA) requested that the manufacturer of Belviq, Belviq XR (lorcaserin) voluntarily withdraw the weight-loss drug from the U.S. market because a safety clinical trial shows an increased occurrence of cancer with long term use. The drug manufacturer, Eisai has submitted a request to voluntarily withdraw the drug.

Although the risk was small (0.6% increased risk compared to those taking placebo), the FDA felt this warranted removal from the market. There does not appear to be an increased risk of cancer in the initial months of treatment, but the risk is increased with longer duration on Belviq.

You should stop taking Belviq and call the office to schedule an appointment to discuss alternative weight-loss medicines and/or weight management programs.

The FDA is not recommending special screening for patients who have taken Belviq.  As with any individual patient, regardless of prior Belviq treatment, standard screening recommendations for cancer should be implemented.

Author
Scott Isaacs, MD Endocrinologist and Weight Loss Specialist

You Might Also Enjoy...

Top Strategies to Make the Holidays Healthier

What foods will you ADD to your shopping list and your menu? Make sure you have plenty of condiments, add-ins, extra HMR foods and fruits and vegetables on hand. Prep and plan as much as you can in advance, so you have meals and snacks ready.

Addressing weight regain after bariatric surgery

The average weight loss for patients who undergo bariatric surgery is around 33% of initial body weight compared to an average weight loss of 10% with anti-obesity medications and 3-5% with a low-calorie diet and lifestyle modification.

If It's Not My Thyroid Then What Is It?

Fatigue, weight gain, mood swings, poor concentration, memory issues, sweating, heart palpitations – your internet search says these are all symptoms of thyroid disease…but what happens when thyroid blood tests are actually normal?

Responding to Women’s World Critics

The Woman's World article was intended to debunk fake information from gaslighting functional medicine selling bogus thyroid supplements and promoting magical thyroid diets. I do not approve of the headline. Fatty liver disease is not a thyroid disorder.